| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | EVP, Chief Financial Officer | Chief Financial Officer
1 company
Schneyer Mark C. is an EVP, Chief Financial Officer at ACADIA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 15,310 | $22.50 | $344,475.00 | -41.1% | +26.6% | -34.5% | |
| Apr 6, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 1,916 | $18.16 | $34,794.56 | -20.4% | +31.7% | -1.9% | |
| Feb 24, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 577 | $18.78 | $10,836.06 | -12.3% | +29.2% | +31.0% | |
| Jun 9, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, Chief Financial Officer | Sale+OE | 653 | $17.91 | $11,694.90 | -16.3% | -3.3% | +41.8% | |
| Feb 23, 2022 | ACAD Acadia Pharmaceuticals Inc | Chief Financial Officer | Sale+OE | 553 | $23.80 | $13,161.40 | -20.8% | -35.3% | -22.6% |